- Home
- RNXT vs SCOR Comparison
RNXT vs SCOR Comparison
Compare RNXT & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- SCOR
- Stock Information
- Founded
- RNXT 2012
- SCOR 1999
- Country
- RNXT United States
- SCOR United States
- Employees
- RNXT N/A
- SCOR N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- SCOR Business Services
- Sector
- RNXT Health Care
- SCOR Consumer Discretionary
- Exchange
- RNXT Nasdaq
- SCOR Nasdaq
- Market Cap
- RNXT 35.2M
- SCOR 37.1M
- IPO Year
- RNXT 2021
- SCOR 2007
- Fundamental
- Price
- RNXT $0.78
- SCOR $7.05
- Analyst Decision
- RNXT Strong Buy
- SCOR
- Analyst Count
- RNXT 2
- SCOR 0
- Target Price
- RNXT $7.50
- SCOR N/A
- AVG Volume (30 Days)
- RNXT 371.1K
- SCOR 15.0K
- Earning Date
- RNXT 11-13-2025
- SCOR 11-04-2025
- Dividend Yield
- RNXT N/A
- SCOR N/A
- EPS Growth
- RNXT N/A
- SCOR N/A
- EPS
- RNXT N/A
- SCOR N/A
- Revenue
- RNXT $928,000.00
- SCOR $358,940,000.00
- Revenue This Year
- RNXT $2,895.35
- SCOR $3.45
- Revenue Next Year
- RNXT $313.04
- SCOR $2.59
- P/E Ratio
- RNXT N/A
- SCOR N/A
- Revenue Growth
- RNXT N/A
- SCOR 0.77
- 52 Week Low
- RNXT $0.70
- SCOR $4.39
- 52 Week High
- RNXT $1.69
- SCOR $10.18
- Technical
- Relative Strength Index (RSI)
- RNXT 31.87
- SCOR 39.82
- Support Level
- RNXT $0.91
- SCOR $6.42
- Resistance Level
- RNXT $1.09
- SCOR $7.26
- Average True Range (ATR)
- RNXT 0.09
- SCOR 0.50
- MACD
- RNXT -0.02
- SCOR -0.11
- Stochastic Oscillator
- RNXT 14.69
- SCOR 5.44
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.